AstraZeneca's partnership spree of the last two months has gone Down Under. As the company shrinks its internal...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
BUSINESS OF BIOTECHNOLOGY
They're perfecting scientific developments that could cure the world's toughest diseases, improve food production, and even yield energy alternatives. This is the exciting world of biotechnology, where young companies fight to make innovative discoveries -- and to find new and innovative ways of funding those innovations.
Business of Biotechnology is part of Business Exchange, suggested by
Arlene Weintraub.
This topic contains
1,248 news
and
4,696 blog
items.
Read updated news, blogs, and resources about Business of Biotechnology. Find user-submitted articles and reactions on Business of Biotechnology from
like-minded professionals.
Blogs
Recent blog posts on this topic.
Copyright © thinkBiotech I continue to measure global biotechnology innovation in the fifth edition of Scientific...
Panel from left to right: Jose-Carlos Gutiérrez-Ramos, Pfizer; Briggs Morrison, AstraZeneca; John Carroll,...
The city of Chicago is hoping to take advantage of the spotlight of the annual BIO convention to build up its biotech...
Copyright © thinkBiotech This infographic from DrugPatentWatch shows that Sanofi Aventis...
Here's a multibillion-dollar question: With their improved cash positions, will pharma companies increase spending this...
After delivering data from multiple rounds of trials on all-oral combos against hepatitis C, pharma runners appear to...
Copyright © thinkBiotech Join Michael Salgaller and I as we will be signing our books at the BIO bookstore on Tuesday...
Public biotech companies around the world stayed on a healthy pace last year, boosting top and bottom-line revenue...
Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.
Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.
GlaxoSmithKline ($GSK) has a new plan to improve the economics of investing in drug discovery. The London-based drug...
Copyright © thinkBiotech This is a guest post from Susan K Finston, President of Finston Consulting. Do you have a...
CEO pay in Europe continues to be a flashpoint given the high unemployment and austerity measures the workaday folk on...
Like most of its new drug programs in recent years, Merck's ($MRK) work on new hepatitis C drugs has never quite paid...
Ask any biotech exec in the business of drug and device development about the funding environment these days, and...
Copyright © thinkBiotech This infographic shows the pharmaceutical companies that listed the most patents last year.
While AstraZeneca's busy business development team was fashioning a new discovery deal with Bind Therapeutics in...
Copyright © thinkBiotech These infographics from DrugPatentWatch.com and BiologicPatentWatch.com track innovation and...
AstraZeneca has found another partner in an ongoing love fest with biotech startups. The drug giant ($AZN), which is in...
Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.
Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.
Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.
Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.
Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.
Top Sources: Business of Biotechnology
- Biotech Blog
- News
- Health Beat
- frontendofinnovation.blogspot.com
- Nature Biotechnology
- The Biotech Weblog
- policyinnovations.org
- Science Progress
- LinkedIn Answers: Technology
- World Pharma News / Published News
account